sarcosine has been researched along with methylene blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aeschlimann, C; Cerny, T; Küpfer, A; Wermuth, B | 1 |
| Akiyama, H; Arai, T; Hasegawa, M; Hosokawa, M; Masuda-Suzukake, M; Nonaka, T; Yamashita, M | 1 |
2 other study(ies) available for sarcosine and methylene blue
| Article | Year |
|---|---|
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Topics: Administration, Oral; Adolescent; Antidotes; Bone Neoplasms; Brain Diseases; Drug Overdose; Female; Glutarates; Humans; Ifosfamide; Injections, Intravenous; Lung Neoplasms; Methylene Blue; Osteosarcoma; Premedication; Sarcosine | 1994 |
Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice.
Topics: Amino Acid Substitution; Animals; Brain; Immunoblotting; Immunohistochemistry; Methylene Blue; Mice; Mice, Transgenic; Mutant Proteins; Phosphorylation; Protein Structure, Quaternary; Sarcosine; Solubility; Subcellular Fractions; tau Proteins | 2012 |